Properties
Description
Paprotrain is designed to block the activity of dual-specificity tyrosine-regulated kinase (DYRK), which are involved in various cellular processes including cell differentiation and survival. It targets MKLP-2.
Molecular Formula
C16H11N3
Identity
Confirmed by NMR/HPLC/MS.
Applications
Paprotrain can be used to inhibit the mitotic kinesin Eg5, studied in cancer research.